Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Smaranda Leu-Semenescu"'
Publikováno v:
Sleep Medicine Clinics
Sleep Medicine Clinics, WB Saunders, 2019, 14, pp.333-350. ⟨10.1016/j.jsmc.2019.05.007⟩
Sleep Medicine Clinics, WB Saunders, 2019, 14, pp.333-350. ⟨10.1016/j.jsmc.2019.05.007⟩
Idiopathic hypersomnia (IH) is characterized by excessive daytime sleepiness despite normal or prolonged sleep. IH is distinguished from narcolepsy by the female predominance, severe morning inertia, continuous drowsiness (rather than sleep attacks),
Autor:
Smaranda Leu-Semenescu, Jean-Baptiste Maranci, Régis Lopez, Xavier Drouot, Pauline Dodet, Ana Gales, Elisabeth Groos, Lucie Barateau, Patricia Franco, Michel Lecendreux, Yves Dauvilliers, Isabelle Arnulf
Publikováno v:
J Clin Sleep Med
STUDY OBJECTIVES: To assess the frequency, determinants, and clinical impact of clinical rapid eye movement (REM) and non-REM (NREM) parasomnias in adult patients with narcolepsy type 1 (NT1), narcolepsy type 2 (NT2), and idiopathic hypersomnia compa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9e36848e595e7bb3c7b27e464d4bbb30
https://europepmc.org/articles/PMC9059608/
https://europepmc.org/articles/PMC9059608/
Autor:
Romy Beauté, Smaranda Leu-Semenescu, Emma Chabani, Pauline Dodet, Isabelle Arnulf, Marie Charlotte Vionnet
Publikováno v:
Consciousness and Cognition
Consciousness and Cognition, Elsevier, 2020, 81, pp.102931. ⟨10.1016/j.concog.2020.102931⟩
Consciousness and Cognition, Elsevier, 2020, 81, pp.102931. ⟨10.1016/j.concog.2020.102931⟩
International audience; At the extreme spectrum of consciousness during sleep, some patients with rare hypersomnias reported experiencing a specific night 'blackout' when sleeping, i.e., an absence of experiences or recall of them from sleep onset to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::93725aeb55abfbdff8318d5d8ff77c86
https://hal.sorbonne-universite.fr/hal-02880847/document
https://hal.sorbonne-universite.fr/hal-02880847/document
Autor:
Clara Odilia Inocente, Michel Lecendreux, Yves Dauvilliers, Isabelle Arnulf, Smaranda Leu-Semenescu, Nandini Nittur, Sabine Scholtz, Valérie Cochen De Cock, Sophie Bayard, Eric Konofal, Patricia Franco
Publikováno v:
Sleep Medicine. 14:30-36
Mazindol is a tricyclic, anorectic, non-amphetamine stimulant used in narcolepsy and obesity since 1970. This study aimed to evaluate the long-term benefit/risk ratio in drug-resistant hypersomniacs and cataplexy sufferers.By retrospective analysis o
Publikováno v:
Revue Neurologique
Revue Neurologique, Elsevier Masson, 2017, 173 (1-2), pp.32-37. ⟨10.1016/j.neurol.2016.09.015⟩
Revue Neurologique, Elsevier Masson, 2017, 173 (1-2), pp.32-37. ⟨10.1016/j.neurol.2016.09.015⟩
International audience; Idiopathic hypersomnia is a rare, central hypersomnia, recently identified and to date of unknown physiopathology. It is characterised by a more or less permanent, excessive daytime sleepiness, associated with long and unrefre
Autor:
Benjamin Boutrel, Yves Dauvilliers, Smaranda Leu-Semenescu, Isabelle Jaussent, Lucie Barateau, Régis Lopez, Isabelle Arnulf
Publikováno v:
SLEEP
SLEEP, American Academy of Sleep Medicine, 2016, 39 (3), pp.573-580. ⟨10.5665/sleep.5530⟩
SLEEP, 2016, 39 (3), pp.573-580. ⟨10.5665/sleep.5530⟩
SLEEP, American Academy of Sleep Medicine, 2016, 39 (3), pp.573-580. ⟨10.5665/sleep.5530⟩
SLEEP, 2016, 39 (3), pp.573-580. ⟨10.5665/sleep.5530⟩
International audience; STUDY OBJECTIVES:Basic experiments support the impact of hypocretin on hyperarousal and motivated state required for increasing drug craving. Our aim was to assess the frequencies of smoking, alcohol and drug use, abuse and de
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dcceed58f6d8ddbf7e978db5c211d2af
https://hal.archives-ouvertes.fr/hal-01886840
https://hal.archives-ouvertes.fr/hal-01886840
Publikováno v:
Sleep medicine. 17
Background Few stimulants have been evaluated for the treatment of idiopathic hypersomnia (IH). Sodium oxybate (indicated in narcolepsy type 1, NT1) has not been tested in IH patients. Objective The aim of this study is to retrospectively evaluate th
Autor:
Xavier Drouot, Carole Pesenti, Smaranda Leu-Semenescu, Isabelle Jaussent, Fabio Pizza, Giuseppe Plazzi, Séverine Béziat, Yves Dauvilliers, Isabelle Arnulf, Régis Lopez
Publikováno v:
PLoS ONE
PLoS ONE, 2015, 10 (6), pp.e0129386. ⟨10.1371/journal.pone.0129386⟩
PLoS ONE, Public Library of Science, 2015, 10 (6), pp.e0129386. ⟨10.1371/journal.pone.0129386⟩
PLoS ONE, Public Library of Science, 2015, 10 (6), pp.e0129386. <10.1371/journal.pone.0129386>
PLoS ONE, Vol 10, Iss 6, p e0129386 (2015)
PLoS ONE, 2015, 10 (6), pp.e0129386. ⟨10.1371/journal.pone.0129386⟩
PLoS ONE, Public Library of Science, 2015, 10 (6), pp.e0129386. ⟨10.1371/journal.pone.0129386⟩
PLoS ONE, Public Library of Science, 2015, 10 (6), pp.e0129386. <10.1371/journal.pone.0129386>
PLoS ONE, Vol 10, Iss 6, p e0129386 (2015)
International audience; BackgroundDrowsiness compromises driving ability by reducing alertness and attentiveness, and delayed reaction times. Sleep-related car crashes account for a considerable proportion of accident at the wheel. Narcolepsy type 1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::93f6e14d7225638b22dc6c2f9e5d7a42
https://hal.sorbonne-universite.fr/hal-01228014/file/journal.pone.0129386.pdf
https://hal.sorbonne-universite.fr/hal-01228014/file/journal.pone.0129386.pdf
Publikováno v:
Sleep medicine. 15(6)
To evaluate the benefits and risks of pitolisant (a wake-enhancing drug that increases the histamine release in the brain by blocking presynaptic H3 histamine reuptake) in patients with idiopathic (IH) and symptomatic (SH) hypersomnia plus sleepiness
Autor:
Patricia Franco, Smaranda Leu-Semenescu, Xavier Drouot, Jean-Louis Golmard, Yves Dauvilliers, Michel Lecendreux, Isabelle Arnulf, Sophie Lavault
Publikováno v:
Sleep medicine. 12(6)
Background The benefit/risk ratio of modafinil was recently re-evaluated by the European Medicines Agency and was shown to be negative for idiopathic hypersomnia (IH) because of insufficient data. Objective To evaluate the benefit/risk ratio of modaf